معرفی
Sergio Estrada is a researcher and director at Uppsala University's Department of Medicinal Chemistry and Preclinical PET-MRI Platform. His work focuses on nuclear medicine, radiopharmaceutical chemistry, and preclinical imaging.
- Current roles: Director and Researcher
- Institution: Uppsala University
Research interests include:
- PET tracer development for inflammatory and neurodegenerative diseases
- Radiolabeling techniques for peptides and proteins
- Preclinical evaluation of imaging agents in animal models
- Multimodal imaging (PET/SPECT/μCT) for regenerative medicine
- Pharmacokinetics and biodistribution studies
- Collagen and fibrosis targeting radioligands
Recent publications emphasize PET applications in sepsis, fibrosis, amyloid deposits, and bone regeneration. His team develops novel radiotracers for neutrophil elastase, GPR44, and collagen type 1, with preclinical validation in porcine and rodent models. Key methodologies include C-11 and F-18 labeling, dosimetry calculations, and translational imaging research.
Collaborations span Uppsala University's PET-MRI platform and multidisciplinary teams in Sweden. Contact: sergio.estrada@ilk.uu.se
